1. Home /
  2. College & University /
  3. Veterinary Clinical Investigations Center

Category



General Information

Locality: Philadelphia, Pennsylvania

Phone: +1 215-573-0302



Address: 3800 Spruce St, Ste 181 19104 Philadelphia, PA, US

Likes: 560

Reviews

Add review

Facebook Blog



Veterinary Clinical Investigations Center 10.07.2021

Does your dog have a soft tissue sarcoma? We are currently offering various trials for soft tissue sarcomas including the NBD Peptide study and the PSITE study. Both trials offer a credit towards surgery up to $1,500 if your dog is eligible for both studies. Read more about these trials on our website below:... https://www.vet.upenn.edu//clinical-tr/all-clinical-trials Please call 215-573-6610 with any questions or email [email protected].

Veterinary Clinical Investigations Center 28.06.2021

When German Shepard eyes are smiling.... We were just so happy to see Pearl today all dressed up for her recheck visit in the anal fistula clinical trial! How did you celebrate St. Patty’s Day today?

Veterinary Clinical Investigations Center 10.06.2021

Calling all dogs with perianal fistulas! The VCIC is currently enrolling dogs, weighing 33 pounds or more, affected by perianal fistulas to participate in a clinical trial evaluating a novel one-time injection to help manage perianal fistulas and their corresponding symptoms. For more information, please visit https://bit.ly/3dqM7bq or contact the Veterinary Clinical Investigations Center at 215.573.0302 or [email protected].

Veterinary Clinical Investigations Center 14.05.2021

CLINICAL TRIAL FOR DOGS WITH B CELL LYMPHOMA Has your dog been diagnosed with B cell lymphoma or leukemia? If so he or she might qualify for one of two cutting-edge clinical trials at Penn Vet. Dr. Nicola Mason’s translational research group at Penn Vet is evaluating cell-based immunotherapy for dogs with B cell Lymphoma or Leukemia. Both trials are evaluating a type of cell-based treatment known as CAR T cell therapy, where white blood cells known as T cells are genetically ...programmed to seek out and destroy cancerous cells. In one trial, T cells from the canine patient's blood, are collected and modified outside of the body before being infused back into your pet where they will seek out and kill the cancerous B cells. In the second trial, for dogs with advanced relapsed, refractory disease, where we are unable to harvest T cells from the blood to make their own product, we are evaluating using human T cells to target and kill their cancer cells. Patients with newly diagnosed or relapsed B cell lymphoma or leukemia involving the lymph nodes and/or peripheral blood may be eligible for either trial. Both trials are fully funded by federal and private foundation grants. To learn more, please contact the Veterinary Clinical Investigations Center (VCIC) at 215-573-0302 or [email protected], or Dr. Mason at [email protected]